Alpha DNA Investment Management »

Intra Cellular Therapies shares owned by Alpha DNA Investment Management

Quarter-by-quarter ownership of Intra Cellular Therapies (ITCI) shares owned by Alpha DNA Investment Management from 13F filings

Historical chart of Alpha DNA Investment Management investment in Intra Cellular Therapies

Tip: Access up to 7 years of quarterly data

All positions including Intra Cellular Therapies held by Alpha DNA Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intra Cellular Therapies by Alpha DNA Investment Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $584k 8.1k 71.62
2022-12-31 $1.1M 21k 52.92